Impact of Erythropoiesis-Stimulating Agents on Energy and Physical Function in Nondialysis CKD Patients With Anemia: A Systematic Review
- 1 March 2010
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 55 (3) , 519-534
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Health-Related Quality of Life and Hemoglobin Levels in Chronic Kidney Disease PatientsClinical Journal of the American Society of Nephrology, 2009
- C.E.R.A. Corrects Anemia in Patients with Chronic Kidney Disease not on DialysisClinical Journal of the American Society of Nephrology, 2008
- Correction of Anemia with Epoetin Alfa in Chronic Kidney DiseaseNew England Journal of Medicine, 2006
- Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney diseaseAmerican Heart Journal, 2005
- Impact of epoetin alfa on clinical end points in patients with chronic renal failure: A meta-analysisKidney International, 2004
- Combining Anchor and Distribution-Based Methods to Derive Minimal Clinically Important Differences on the Functional Assessment of Cancer Therapy (FACT) Anemia and Fatigue ScalesJournal of Pain and Symptom Management, 2002
- Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement systemJournal of Pain and Symptom Management, 1997
- The Minimum Clinically Important Difference in Physician–assigned Visual Analog Pain ScoresAcademic Emergency Medicine, 1996
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Measurement of health statusControlled Clinical Trials, 1989